+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Gorlin-syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Gorlin-syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Wilms Tumor - Pipeline Insight, 2025 - Product Thumbnail Image

Wilms Tumor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Adrenocortical Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Adrenocortical Carcinoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adenoid Cystic Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Adenoid Cystic Carcinoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Acute Lymphocytic Leukemia (ALL) - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Lymphocytic Leukemia (ALL) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Advanced Recurrent Ovarian Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Recurrent Ovarian Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adult T-Cell Leukemia-Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Adult T-Cell Leukemia-Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Clear Cell Sarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Clear Cell Sarcoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Familial Adenomatous Polyposis - Pipeline Insight, 2025 - Product Thumbnail Image

Familial Adenomatous Polyposis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Desmoid Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Desmoid Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Meningioma - Pipeline Insight, 2025 - Product Thumbnail Image

Meningioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Microsatellite Stable Colorectal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Microsatellite Stable Colorectal Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Anal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Anal Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Myelodysplastic Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Myelodysplastic Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Post-Polycythemia Vera Myelofibrosis - Pipeline Insight, 2025 - Product Thumbnail Image

Post-Polycythemia Vera Myelofibrosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Proto-oncogene Protein C Mdm2 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Proto-oncogene Protein C Mdm2 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Proto Oncogene Protein C-myc Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Proto Oncogene Protein C-myc Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 96 Pages
  • Global
From
Proto Oncogene Proteins C Pim 1 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Proto Oncogene Proteins C Pim 1 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more